03:56 PM, 21st Jan 2026
Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2025